Skip to main content
. 2015 Feb 20;79(3):492–500. doi: 10.1111/bcp.12517

Figure 4.

Figure 4

Placebo-adjusted FEV1 at 24 h (ITT population; mean ± SEM) after different doses of nebulized glycopyrrolate. *P < 0.001 ancova. n = 37–39